Pain syndrome and clinical-biochemical parameters in children with non-surgical treatment of uncomplicated acute appendicitis

Phase 4, open-label, single-arm trial of ketorolac in acute appendicitis, sponsored by Rīga Stradiņš University. Primary endpoints: Feasibility: proportion of approached patients providing consent and Completion of pain assessment and treatment protocol over 72 hours. Planned start Jan 2025; status: authorised.